Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly Debt to Equity Ratio : 1.621 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.621 |
| March 31, 2026 | 1.390 |
| December 31, 2025 | 1.653 |
| September 30, 2025 | 1.786 |
| June 30, 2025 | 2.184 |
| March 31, 2025 | 2.443 |
| December 31, 2024 | 2.371 |
| September 30, 2024 | 2.185 |
| June 30, 2024 | 2.130 |
| March 31, 2024 | 2.046 |
| December 31, 2023 | 2.342 |
| September 30, 2023 | 1.798 |
| June 30, 2023 | 1.701 |
| March 31, 2023 | 1.688 |
| December 31, 2022 | 1.525 |
| September 30, 2022 | 1.578 |
| June 30, 2022 | 1.968 |
| March 31, 2022 | 1.769 |
| December 31, 2021 | 1.880 |
| September 30, 2021 | 2.203 |
| June 30, 2021 | 2.563 |
| March 31, 2021 | 2.349 |
| December 31, 2020 | 2.942 |
| September 30, 2020 | 3.506 |
| June 30, 2020 | 3.989 |
| Date | Value |
|---|---|
| March 31, 2020 | 5.596 |
| December 31, 2019 | 6.109 |
| September 30, 2019 | 4.645 |
| June 30, 2019 | 5.858 |
| March 31, 2019 | 6.642 |
| December 31, 2018 | 1.048 |
| September 30, 2018 | 0.9694 |
| June 30, 2018 | 1.058 |
| March 31, 2018 | 0.8052 |
| December 31, 2017 | 1.177 |
| September 30, 2017 | 0.9043 |
| June 30, 2017 | 0.8731 |
| March 31, 2017 | 0.7303 |
| December 31, 2016 | 0.7357 |
| September 30, 2016 | 0.5997 |
| June 30, 2016 | 0.6375 |
| March 31, 2016 | 0.5414 |
| December 31, 2015 | 0.5475 |
| September 30, 2015 | 0.5308 |
| June 30, 2015 | 0.5453 |
| March 31, 2015 | 0.551 |
| December 31, 2014 | 0.5241 |
| September 30, 2014 | 0.3173 |
| June 30, 2014 | 0.2953 |
| March 31, 2014 | 0.2871 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Merck & Co., Inc. | 1.286 |
| Pfizer Inc. | 0.7418 |
| Bristol Myers Squibb Co. | 2.019 |
| Atai Beckley, Inc. | 0.0107 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 142.28B |
| Total Liabilities (Quarterly) | 108.40B |
| Shareholders Equity (Quarterly) | 33.88B |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -0.29% |